Cape Investment Advisory’s CVS Health CVS Stock Holding History

Cape Investment Advisory’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$299K	Buy	+2,895	New	+$258K	0.08%	179
2026 Q1	–	Sell	-1,935	Closed	-$154K	–	421
2025 Q4	$154K	Buy	1,935 +687	+55%	+$54.2K	0.05%	238
2025 Q3	$94.1K	Sell	1,248 -59	-5%	-$4.04K	0.09%	170
2025 Q2	$90.1K	Buy	1,307 +21	+2%	+$1.38K	0.03%	283
2025 Q1	$87.2K	Buy	1,286 +11	+0.9%	+$658	0.03%	266
2024 Q4	$57.2K	Buy	1,275 +452	+55%	+$25.4K	0.02%	314
2024 Q3	$51.7K	Sell	823 -7,534	-90%	-$440K	0.02%	316
2024 Q2	$494K	Buy	8,357 +296	+4%	+$18.5K	0.22%	77
2024 Q1	$643K	Buy	8,061 +46	+0.6%	+$3.51K	0.3%	70
2023 Q4	$633K	Buy	8,015 +251	+3%	+$17.9K	0.31%	64
2023 Q3	$542K	Buy	7,764 +3,946	+103%	+$280K	0.31%	63
2023 Q2	$264K	Buy	3,818 +11	+0.3%	+$783	0.15%	107
2023 Q1	$283K	Buy	+3,807	New	+$319K	0.17%	94

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Cape Investment Advisory's CVS Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in CVS Health (CVS) in Q2 2026: 2,895 shares worth $299K. The stake represents 0.08% of the portfolio and ranks #179 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in CVS as recently as Q4 2025.

Cape Investment Advisory first reported a position in CVS in Q1 2023 and has held it in 13 quarters since. The position peaked at $643K in Q1 2024. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Cape Investment Advisory held 2,895 shares of CVS Health worth $299K as of Q2 2026.
CVS Health was a new Cape Investment Advisory position in Q2 2026.
CVS Health made up 0.08% of Cape Investment Advisory's portfolio in Q2 2026, its #179 holding.
Cape Investment Advisory first reported a position in CVS Health in Q1 2023 and has held it in 13 quarters since.
Cape Investment Advisory's CVS Health position peaked at $643K in Q1 2024.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.